INTRODUCTION
The group A streptococcus (Streptococcus pyogenes) is responsible for a number of suppurative human infections, of which acute pharyngitis and impetigo are the most common. As a consequence of ineffective antibiotic therapy or no therapy, as many as 3 to 5% of individuals who suffer a group A streptococcal pharyngeal infection may develop acute rheumatic fever (32, 204) , a disease often resulting in cardiac damage. While not currently a major problem in developed countries, rheumatic fever is the leading cause of heart disease in school-age children in developing nations (1). For instance, by one estimate, over 6 million school-age children in India are afflicted with rheumatic heart disease (1). Acute glomerulonephritis, another sequela of group A streptococcal disease, is usually the consequence of infection by specific strains of streptococci (nephritogenic strains) which infect either the throat or skin (174) . The ability of group A streptococci to persist in infected tissues is primarily due to the cell surface M protein, a molecule which confers to the streptococcus the ability to resist phagocytosis by polymorphonuclear leukocytes in the absence of type-specific antibodies. Resistance to a group A streptococcal infection appears to be related to the presence of type-specific antibodies to the M molecule (128, 129) . Since there are >80 different serotypes of M protein (i.e., M5, M6, M24, etc.), an individual may become infected by more than one group A streptococcal type during a lifetime (129) .
Streptococcal M protein was identified over 60 years ago by Rebecca Lancefield (126) . A review by Lancefield in 1962 (129) clearly describes the studies carried out for nearly 35 years, defining this molecule as a major virulence factor for the streptococcus due to its antiphagocytic property. In 1974, a comprehensive review by Fox (81) delineated studies since the Lancefield review and underscored the knowledge to that time of the structure, function, and immunochemistry of the M molecule.
The streptococcal M protein is now probably one of the best-defined molecules of the known bacterial virulence determinants. Its structure, function, immunochemistry, and method of antigenic variation are unique among known virulence molecules and may serve as a model for certain microbial systems. To better appreciate the thinking which led to the current understanding of the M protein, whenever possible, attempts will be made to present this review in an historical perspective, with a chronological account of the studies over the years, emphasizing the time since 1974. While the antiphagocytic activity and genetics of the M molecule will be addressed in this review, the reader is also directed to recent reviews by Manjula (131) and Scott (J. R. Scott, in B. Iglewski, ed., The Bacteria, Vol. XIII, in press) on these subjects.
In this review, the basic structure of the M molecule will be developed. Once established, it then becomes a simple matter to integrate this information into a better awareness of the biology of the M molecule and its relation to type specificity, antigenic diversity, and cross-reactivity. With these concepts understood, a strategy to control group A streptococcus-related diseases may become more apparent. ELECTRON 
MICROSCOPY Thin Sections
Thin-section electron micrographs identifying the M protein on the surface of group A streptococci were first published by Swanson et al. (193) , using ferritin-labeled M-specific antibodies derived from type-specific rabbit sera. The data suggested that M protein appears as hairlike projections on the surface of the streptococcal cell wall ( Fig.  1) (13, 169) . M-streptococci were found to be devoid of these surface projections (193) .
Whole Streptococci To better appreciate the features of the proteins on the surface of the streptococcal cell wall, organisms were prepared for electron microscopy by a variety of other techniques (68) . Whole streptococci mounted on grids, criticalpoint dried, and viewed under a transmission electron microscope exhibit projections which appear to be the result of interactions among several adjacent M-protein fibrils forming tuftlike structures ( Fig. 2a and b) . Interactions between M molecules on adjacent streptococci, previously observed in thin sections ( Fig. 1) (169) , are also seen in these preparations. Whether these surface structures are composed exclusively of M protein or are the result of complexes of M protein and lipoteichoic acid (LTA) or other surface molecules was not determined. However, ferritin-labeled anti-M antibodies reveal that the extensions do contain M protein (Fig. 3) . Surface replica preparations confirm the presence of these types of projections on the cell surface of whole organisms (Fig. 4 ). Streptococci treated with trypsin to remove the M protein were shown to have a smooth surface in all of these preparations (not shown).
In experiments designed to answer questions about the placement of M protein on the cell wall, Swanson et al. (193) found that, after trypsinization to remove existing M protein on living streptococci, newly synthesized M protein was first seen by electron microscopy on the cell in the position of the newly forming septum. In similar experiments designed after the classical experiments of Cole and Hahn and using fluorescein-labeled anti-M antibodies (44) , trypsinized streptococci placed in fresh media for 10 min revealed M protein first at the newly forming septum (Fig. 5a ). On organisms examined after extended incubation, M protein was not observed in the position of the old wall (Fig. 5b) , suggesting that the M molecule is produced only where new cell wall is synthesized (193) .
ISOLATION AND PURIFICATION For many years the method used to prepare crude M protein for purification was based on the one developed by Lancefield (126) for the preparation of extracts for streptococcal typing (for references prior to 1974, see Fox [81] and Lancefield [129] ). According to this procedure, organisms are suspended in dilute HCI at pH 2.0 and placed in a boiling-water bath for 10 min. After neutralization, the resulting extract is centrifuged and the supernatant is used as starting material for further characterization of the M mole- cule. While the procedure effectively removes M protein from the cell, it is unlikely that the final purified product represents the native M-protein molecule (82) . Recognizing this limitation, other procedures for extracting M protein from whole streptococci or their isolated cell walls were attempted. These included sonic oscillation (25, 157) , alkali (47, 84) , group C bacteriophage-associated lysin (43, 79) , nonionic detergent (64, 65) , nitrous acid (91) , cyanogen bromide (202) , and guanidine hydrochloride extraction (178) , all of which were usually coupled to a particular purification scheme. However, in nearly all cases the final purified M protein exhibited extensive heterogeneity. These results led to the general conclusion at that time that M protein was composed of a heterogeneous group of molecules or of multiple subunits (82) .
Pepsin, Detergent, and Lysin Extraction The biochemical features of the M-protein molecule became more apparent with the development of an extraction procedure which specifically cleaves the M protein from the streptococcal surface. Pepsin digestion at a suboptimal pH of 5.8 releases a biologically active fragment of the M protein (termed PepM) from the cell wall (11, 46) . After purification. the fragment is found to be homogeneous by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, strongly suggesting that the M molecule on the cell surface was also likely to be homogeneous, contrary to previous belief. Depending on the serotype, the size of the extracted PepM molecule varies from 20,000 to 40,000 in molecular weight (34, 116, 120, 133, 152, 169) . When injected into rabbits, the pepsin-derived fragment elicits antibodies capable of initiating phagocytosis of streptococci of the homologous serotype. PepM can also absorb type-specific opsonic antibodies from serum (11, 137) . Thus, the pepsin-derived M-protein fragment retains some of the biologically important determinants of the native M molecule present on the streptococcal surface. Pepsin extraction, therefore, proved to be one of the better methods for obtaining a workable fragment of the M protein and was used to provide the starting material in a variety of studies over the ensuing years (14, 18, 22, 117, 133, 137, 152, 158, 169) . Although it was believed early on that pepsin removed the M protein in its entirety from the streptococcal surface (13) , the nature of the complete molecule was not as yet understood.
Nonionic detergent was found to remove M protein from isolated streptococcal cell walls (70) . The M molecule released by this method is seen by sodium dodecyl sulfatepolyacrylamide gel electrophoresis as several closely spaced protein bands which range from 15,000 to 35 .000 in molecular weight. Like pepsin-extracted M protein, the detergentextracted molecules are able to absorb opsonic antibodies from rabbit antiserum (70) and evoke type-specific opsonic antibodies when injected into rabbits (64) . An examination of the physicochemical properties of these M molecules re-VOL. 2, 1989 on October 26, 2017 vealed that they are not globular but asymmetrical, with a frictional ratio of 2.2 (70) . Thus, the detergent-extracted M molecules, though not as homogeneous as the pepsin-derived protein, display many of the properties of PepM.
It was not until 1981, when M protein was purified from the extracellular supernatants of type 12 group A streptococcal L forms and protoplasts, that it became apparent that the size of the native M molecule could be as large as 58 kilodaltons (kDa) (199) . Extraction of M protein from streptococci by solubilization of the cell wall with phage lysin (termed lysin, a muralytic enzyme produced during a group C streptococcal phage infection [69] ) also yielded a large M molecule (43, 79) ; however, the association of this M protein with cell wall fragments, resulting in its high molecular weight, could not be ruled out.
STRUCTURAL ANALYSIS Evidence for the Coiled-Coil Structure of M Protein
Though sequence and peptide data were limited up to 1979, the available information suggested that M molecules of heterologous serotypes differed in primary structure in spite of a common antiphagocytic activity (18, 65 ever, despite these apparent differences, physical and chemical data accumulated to that time revealed that all of the M molecules examined shared certain noteworthy properties (81) . Their extreme thermal stability (126) , elongated shape (70, 84, 166) , and appearance as a network of fibers on the cell surface (193) suggested that M molecules resemble previously characterized fibrous proteins. When the partial sequence of the PepM24 (terminology used for the M protein extracted from M24 streptococci with pepsin) protein (18) was compared with that of known proteins, two of the M24 cyanogen bromide peptides exhibited up to 40%Y identity with rabbit skeletal muscle tropomyosin (99) . In addition, a hexapeptide, repeated five times in the PepM24 molecule, was identical to a sequence in tropomyosin. This was the first direct evidence that M protein may be structurally similar to tropomyosin, the prototype molecule for an othelical coiled-coil fibrillar protein (145) . The isoelectric point (a reflection of amino acid composition), solubility, heat stability, and stability in acid and base of tropomyosin were similar to those found for M protein, further confirming the chemical and structural relationship of these two molecules (99) .
Additional biochemical support for the probable coiledcoil structure of M protein came when the partial sequences of the M5, M6, and M24 proteins were compared with that of tropomyosin (136) . The sequences within these three molecules contained a repeating seven-residue periodicity of nonpolar amino acids, a basic characteristic of x-helical coiled-coil proteins like tropomyosin. A more detailed study of the structure and conformation of the PepM6 and lysinextracted M6 proteins further established the close relationship between M protein and tropomyosin (169) . In this analysis, ultracentrifugation studies revealed that the M molecules exist as stable dimers, and circular dichroism spectra indicated that the molecules are 70% a-helical. Electron microscopic images of platinum-shadowed M molecules were seen as rods in which the pepsin-and detergentextracted forms were approximately half the length of the lysin-extracted protein. Measurements also revealed that the M molecules were similar in width to tropomyosin, and fiber X-ray diffraction indicated that a coiled-coil structure is present in the M molecule. Assessment of M protein on the streptococcal surface compared with isolated M molecules indicated that each fiber on the cell wall consists of a single dimeric M-protein molecule of about 50 to 60 nm in length ( Fig. 1) and is not composed of multimers of smaller subunits as is the case for pili of gram-negative organisms (33) . Though common in mammalian cells, the x-helical coiledcoil design is unique for bacterial surface molecules (41, 42) .
Studies by Phillips et al. (169) 4 . Tantalum and tungsten surface replica of critical-point-dried streptococci revealing the distribution of the projections on the cell surface. Magnification, x96,000.
molecule. M proteins extracted with pepsin are almost half the size of the lysin-extracted molecule and are likely cleaved products derived from the native M molecule. This is further supported by electron micrographs of pepsintreated M-bearing (M F) streptococci depicting shorter surface fibers than untreated cells (13, 169) . Thus, after pepsin digestion, roughly half of the M molecule remains associated with the streptococcal cell.
Structural Analysis of the Complete M Molecule
The completion of the PepM5 sequence (133) allowed for the first time a thorough analysis of this region of an M molecule (141), i.e., the distal half of the native protein (169) .
The results confirmed what previous partial sequence data had suggested: except for the N-terminal 11 amino acids, the remainder of the sequence exhibits a seven-residue periodicity in the distribution of nonpolar amino acids. In addition, it revealed that the N-terminal region of this fragment contains a significantly higher net negative charge than the C-terminal region. While sequence repeats were also identified in the PepM5 molecule (139) , they were not as extensive as those found in the partial PepM24 sequence (18) .
Until 1986, the majority of structural information was based on the pepsin fragment of the M molecule. No information, besides the physicochemical analysis on the lysin-extracted M protein (169) , was available concerning the C-terminal half. The successful cloning of the M6 gene (enzin-6) (180) resulted in the ability to determine the complete amino acid sequence of an entire M molecule (94) . Like the partial PepM24 sequence (18, 19) M5 (148) , and M12 (175) proteins, the M5 molecule being the least repetitive. A C-terminal segment, composed of 19 hydrophobic amino acids, is predicted to have an a-helical conformation which would be sufficient in length to traverse the cytoplasmic membrane (77) . An adjacent region, rich in proline and glycine, is predicted to be located within the cell wall peptidoglycan (161) .
Basic Model
In general, x-helical coiled-coil proteins are constructed from a repeating seven-residue amino acid pattern (a-bc-d-e-f-g)n in which residues in positions a and d are hydrophobic and form the "core" residues in the coiled-coil and the intervening residues are primarily helix promoting (145) . The arrangement of the amino acids of the M6 protein within the seven-residue pattern is shown in Fig. 7 . The sevenresidue periodicity found from amino acids 12 through 362 strongly suggests that this region is in a coiled-coil conformation and forms the helical central rod region of the molecule. Discontinuities in the heptad pattern (seen especially in repeat B), which have been seen in the sequence of other M proteins (141) and other coiled-coil molecules (144, 163, 166) , probably account for the flexibility of the M molecules observed in electron micrographs (Fig. 1) . Based on these irregularities in the heptad pattern, the central rod region is divided into three subregions which correlate with the A-, B-, and C-repeat blocks (77) .
Based on a detailed analysis of data of M-protein sequences, it was concluded that serologically different M proteins may be built according to a basic scheme: an extended central coiled-coil rod domain flanked by functional end domains (77) . Because the Q-helical coiled-coil is a structure capable of tolerating a vast number of amino acid sequence changes while preserving its conformation, a large (77, 94) . Blocks A, B. C, and D designate the location of the sequence repeat blocks. Numbers above the block indicate the number of amino acids per block. Block C3 is half the size of blocks C1 and C2. Shadowed blocks in A and B indicate those in which the sequence diverges from the central consensus sequence. In the C repeats, the sequence in the center of C1 and C2 are identical, while the sequence at the ends and block C3 diverge. Pro/Gly denotes the proline-glycine-rich region likely located in the peptidoglycan. Membrane anchor is a 19-hydrophobic-amino-acid region adjacent to a 6-amino-acid charged tail. Pepsin identifies the position of the pepsin-susceptible site after amino acid 228. Wall-associated region designates the segment of the molecule located within the cell (this begins at Ala-298 in the C2 block [161] ). based on current sequence and structural data (77, 94) . The coiledcoil rod region extends about 50 nm from cell wall with a short nonhelical domain at the N terminus distal from the cell surface. The proline-glycine-rich region of the molecule is located within the peptidoglycan, with a short segment of the coiled-coil rod region positioned in the group carbohydrate portion of the wall (161) . The membrane anchor segment extends through the cell membrane, with the charged tail projecting into the cytoplasm. Regions containing conserved, variable, and hypervariable epitopes among heterologous M serotypes are indicated. Because 3.6 residues are necessary to achieve one turn of the helix (102) , hydrophobic residues at positions a and d in the heptad (Fig. 7) will form an inclined stripe around the helix. For thermodynamic stability, a dimeric, ropelike superstructure would be formed as a result of the internalization of the hydrophobic residues from two helical chains coiling around each other (75, 136, 145) (Fig. 8) A short 11-residue nonhelical region is found at the N-terminal end of the coiled-coil rod region, which is distal to the cell surface (Fig. 8) . In all M proteins examined thus far, except M49, which lacks this segment (116) , the sequence of this region is distinct from one M type to another (94, 133, 148, 153, 175) but is nearly 100% identical within an M type (95) . It is not certain whether the tertiary conformation of this N-terminal region is similar among the different M-protein types despite sequence variation. The N-terminal segment plays an important role in the biological activity of the molecule, since antibodies generated to this region effectively opsonize the streptococcus of the M type from which it was derived (12, 15, 34, 55, 57, 106, 107 ) (see below). Thus, it seems likely that one purpose for the central rod region may be to act as a shaft to position the N-terminal region away from the cell surface (Fig. 8) .
Beginning at the C-terminal end of the central rod region is a segment characterized by the presence of regularly spaced prolines and glycines (Fig. 7) . This is followed by two phenylalanine residues beginning at residue 417 which signal the start of a 19-amino-acid stretch of hydrophobic residues terminated by six charged amino acids. It was suggested that the hydrophobic amino acids would serve as a membrane anchor and the adjacent proline-glycine region would be located in the peptidoglycan and act to stabilize the molecule within the cell wall (77) . The charged tail, typical of a stop transfer signal seen in the membrane-associated segments of several membrane-bound proteins (178a) (Fig. 7) .
Further evidence suggested that residues 298 to 362 of the helical rod region are located within the group carbohydrate moiety of the cell wall, localizing the proline-glycine region within the peptidoglycan. Since no detectable amino sugars were found with the wall-associated M-protein fragment, it is likely that the C-terminal region of the M6 molecule is intercalated within the group carbohydrate and cross-linked peptidoglycan and not covalently linked to them (161) .
M protein is rarely detected in the spent growth media of streptococci. Therefore, the incorporation of this molecule into the cell wall and membrane appears to be closely regulated. It is postulated that the C-terminal membrane anchor may be necessary to keep the M molecule attached in the right orientation within the cell membrane until such time as the peptidoglycan is cross-linked (156) around the prolineglycine region. Recent studies (V. Pancholi and V. A. Fischetti, submitted for publication) have revealed that at pH 5.5 in the presence of 30% raffinose, the streptococcal cell wall may be removed with a muralytic enzyme, allowing nearly all the M protein to remain attached to the protoplast membrane. Shifting the protoplasts to pH 7.4 results in the release of the M molecule into the supernatant. A membrane-bound thiol enzyme was found to be responsible for the release. The biological significance of such an enzyme is currently speculative. Since the released form of the M molecule lacks the C-terminal 19 hydrophobic amino acids and charged tail (161) , its attachment to the cell appears to be through the cytoplasmic membrane.
Domain Structure
Techniques using limited proteolysis have been effective in defining functional and structural domains in a variety of proteins (215) , particularly immunoglobulins (88, 167, 185) . Similarly, the PepM fragment of the M protein may be regarded as a functional domain and the pepsin-susceptible site may be seen as a hinge region of the molecule. This preferential site for pepsin at a suboptimal pH is found between the B-and C-repeat blocks in M5 (147), M6 (94) , and M24 (153) proteins (Fig. 6 ) even though the B-repeat block in M24 is not homologous with that found in M5 and M6. PepM49, however, has a primary pepsin site after a C-repeat block and a secondary site between the B and C repeats (135) . Thus, since the type-specific and antiphagocytic determinants are located within the PepM fragment, this half of the M molecule may be considered to be a functional domain of the protein. However, besides the wall and membrane anchor domains, the functional attributes of the C-terminal domain comprising the C-and D-repeat blocks have yet to be clearly defined.
Thus, the streptococcus uses the coiled-coil design to accomplish a variety of tasks. The rodlike conformation allows the functional antiphagocytic domain to be positioned away from the cell wall. The plasticity of the sequences necessary to form the coiled-coil structure allows the different domains of the molecule to be tailored for specific functions.
IMMUNOCHEMISTRY
The M-protein molecule is the basis of the Lancefield serotyping scheme of group A streptococci (126, 177, 195) . The typing sera used for this purpose are a set of Mprotein-specific rabbit sera prepared against whole organisms of specific serotypes. To remove cross-reactive antibodies, sera are extensively absorbed with organisms of selected heterologous serotypes. Nearly 80 (80, 83) .
It was clear that immunization of rabbits with the PepM fragment resulted in antibodies which were essentially type specific and opsonic and were free of extensive reactivity to non-type-specific epitopes found previously with acid-extracted M proteins (21) . Peptide map analysis of M protein (derived from the N-terminal half of the molecule) from cross-reactive and non-cross-reactive serotypes revealed that cross-reactions correlated with the extent of structural similarity among the M molecules analyzed (65) . Limited cross-reactions were observed when 125I-labeled M6 protein, representing the N-terminal half of the molecule, was used in a radioimmunoassay with unabsorbed rabbit antiserum prepared to heterologous M serotypes (64) . Using monoclonal antibodies, Dale and Beachey (52) found that some antibodies cross-reacted with purified PepM proteins from certain other serotypes; however, the location of these epitopes was not defined. Thus, it was clear that, while cross-reactive epitopes were present in the N-terminal half of the M molecules, they were apparently limited in scope.
Conserved, Variable, and Hypervariable Epitopes Using polyclonal rabbit antisera to M6 protein, Manjula et al. (132) found cross-reactivity with the C-terminal region of the PepM5 molecule (located near the center of the native molecule), whereas no reactivity was observed with the N-terminal region of the PepM5 molecule. The results suggested that the N-terminal 25% of the native M molecule may represent a hypervariable region of M proteins. In support of this, Dale et al. (55, 57) established that synthetic peptides derived from the N-terminal sequence (residues 1 to 20) of the M5 molecule stimulated type-specific antibodies which did not cross-react with M protein from other serotypes. This was later proven also to be true for M6 (15, 106) , M19 (34) , and Ml (120) proteins.
Monoclonal antibodies directed to the N-and C-terminal halves of the native M6 protein were used by Jones et al. (109) in an attempt to identify the location of the epitopes accountable for limited and broad cross-reactions among M serotypes. Results revealed that an epitope responsible for cross-reactions among 5 of 56 serotypes was located in the N-terminal half of the molecule (within the B repeat) while a highly cross-reactive epitope (reactive with 20 of 56 serotypes) was located in the C-terminal half (within the C repeat) (Fig. 6 ). These studies were extended with two other monoclonal antibodies, one reacting with an epitope at the N-terminal end within the A-repeat region and one in the C-terminal half within the C-repeat (106, 108) . The Cterminal antibody cross-reacted with 30 different serotype strains, while the new N-terminal monoclonal antibody was found to be type specific and reacted only with the M6 serotype strain. This monoclonal antibody was the only one of the four studied that was opsonic for M6 streptococci.
Thus, it is clear from a variety of immunological techniques that the C-terminal region of the M molecule is antigenically more conserved among different serotypes. As the N-terminal region is approached, the greater the antigenic variation (Fig. 8) . Therefore, the basis of the M-protein typing scheme is now more clearly understood. In the preparation of typing sera, absorption of antistreptococcal antisera with heterologous strains was necessary to remove the antibodies reactive with the conserved regions of the M molecule, in addition to antibodies to other common antigens found on the cell surface. This resulted in what would be expected to be a monospecific antibody population, directed to the type-specific N-terminal region of the M molecule (Fischetti, unpublished data In a recent antigenic analysis of surface-exposed Mprotein epitopes, it became apparent that two basic Mprotein structures exist (28) I antigen is located on another related surface molecule, the evidence that it is M protein is significant (28, 211, 213) . In summary, the MAP I and MAP II M types closely parallel two major structural classes of M-protein molecules, termed classes I and II, respectively. Streptococci bearing class I M proteins share surface-exposed antigenic epitopes with the C-repeat region of M6 protein and fail to produce OF, whereas class II serotypes produce OF but are deficient in epitopes cross-reactive with the M6-like C-repeat region (28) .
The close proximity of the highly conserved C-repeat region to the poorly homologous B-repeat and pepsin sites strongly suggests that the C-repeat region forms a distinct antigenic domain (28) (Fig. 6 ). In support of the immunochemical analysis, structural data suggest that the C-repeat antigenic domain may have unique conformational characteristics as well. The B-repeat region through residue 230 forms a more flexible coiled-coil structure than the C-repeat region beginning at residue 231 (77) . In addition, amino acid sequence identity between maximally aligned sequences of M6 (94) and M12 (175) is <27%Y between residues 121 and 231, but abruptly increases to 97% complete identity between residues 232 and 298 (extending from the beginning of the first C-repeat subblock to the perimeter of the cell wall). (Fig. 7) . Thus, the data strongly suggest that the aminoterminal end of the conserved class I M-protein antigenic domain lies at the beginning of the first C-repeat block (28) .
Class I and II M proteins appear to lack immunological cross-reactivity in their surface-exposed regions, however.
antigenic relatedness between class I and II M proteins can be demonstrated in their extracted forms (28) . Whether the shared antigenic epitopes reside in buried portions of the M-protein molecule remains to be established. The degree of homology between M-protein genes of different serotypes has been addressed in nucleic hybridization studies. By using DNA probes corresponding in positions to the Crepeat region and to the cell wall and membrane anchor regions of M6, a class I M protein (147, 182) . distinctions can be made between class I and II serotypes (28) . Hybridization to chromosomal DNA of most class II serotypes is observed only under conditions of low stringency, whereas class I serotypes hybridize under high-stringency conditions. These findings suggest that there are fundamental differences between class I and II M proteins at the DNA level (28).
C-Repeat Domain and Rheumatic Fever
Class I streptococcal serotypes are represented among both skin and nasopharyngeal isolates. Likewise, both throat and skin strains are found among the OF-producing class II serotypes. Thus, the conserved C-repeat domain does not appear to be involved in determining the tissue site of infection. In addition, serotypes associated with acute glomerulonephritis are represented by both class I and II streptococci. However, there is a strong correlation between certain serological M types and outbreaks of acute rheumatic fever (30) . Of 16 streptococcal serotypes which have been associated with one or more major outbreaks of rheumatic fever, all but one type express the C-repeat region epitope which defines class I M protein (28) . Rheumatic fever patients have high complement-fixing titers to MAP I antigen (211) . and MAP I-specific antibodies are absorbed by human heart tissue (213) . Thus, the surface-exposed conserved repeat domain of class I serotypes may be a virulence determinant for rheumatic fever (28) .
SIZE VARIATION IN THE M MOLECULES
In this and following sections, a direct comparison of the known M-protein sequences is presented. But, to fully appreciate the sequence diversity found within M molecules, it is important to understand a recently observed property of the M-protein molecule, namely, size variation. By using a broadly cross-reactive monoclonal antibody as a probe, the size of lysin-extracted M protein from a number of streptococcal strains was examined by Western blot (immunoblot) (74) . M protein derived from streptococcal isolates of 20 different serotypes exhibited variation in size ranging from 41 to 80 kDa, depending on the strain. Similar size variation is observed when different M6 streptococcal strains isolated over a period of 40 years are examined in this way. This variation in size may be explained by the observation that the M sequence contains extensive repeats at the DNA level (94) . Long reiterated DNA sequences are likely to serve as substrates for recombinational events or for replicative slippage (62, 192) , generating deletions and duplications within the M-protein gene and leading to the production of M proteins of different sizes.
Isolation and Sequence Analysis of Size Mutants
To test this hypothesis, it was necessary to isolate clonally related strains of M-protein size mutants in the laboratory, so that the parent and mutants could be compared. A Western blot system was devised so that M-protein size mutants could be detected and isolated if they comprised at least 5% of the culture. From type 6 strain D471, about 1 in 2,000 colony-forming units (CFU) were found to produce a smaller size M protein, a rate that seemed too high to be the result of spontaneous mutation (71) . Analysis of the DNA sequence of the M6 genes of four spontaneous M-protein size mutants confirmed that they arose by recombinational events between reiterated DNA sequences within the structural gene encoding M protein (95) . Each of the mutants bearing smaller-size M protein had a deletion of one or more of the A-or B-repeat blocks (Fig. 9) .
Comparison of aligned sequences of the M6 size variants indicates that extensive changes can occur within this one strain. While the region on the C-terminal side of the last C-repeat sub-block remains highly conserved (95) (Fig. 9) , whereas M6.9 (isolated in the 1940s) has five A repeats (two of which differ in size from the others) and an extra C-repeat segment (95) (data not shown). Sequence analysis of the M6 genes also indicated that the isolates from each clinical group are clonally related and not the result of separate acquisitions of unrelated M6 strains during the course of the infection (95) . When the streptococcal strains isolated weekly from the throats of 15 patients were examined for the size of the M molecule (see Fig. 10 for an example of two such patients), 8 infecting streptococcus isolated from infected individuals exhibits size differences.
ANTIGENIC VARIATION AND ITS RELATION TO SIZE VARIATION
Antigenic diversity of surface antigens is a mechanism by which successful pathogens have been able to survive in the environment after infecting immunocompetent hosts (7, 45, 146, 194) . In bacteria, the best-studied variable antigens are the gonococcal pilin (146, 194) and the Borrelia variable major protein (7) . M protein differs from these other antigenically variable surface proteins in that they undergo gene conversion events involving extragenic recombination between multiple genes, whereas the single copy of emm-6 in streptococci (see below) must involve intragenic recombination events for changes to result.
Clues as to the mechanism of antigenic variation of the M protein are based on two previously mentioned observations: size variation of the M molecule (74) and the presence of repeat sequences within the M-protein gene (94) . Based on these observations, it was hypothesized that changes in the amino acid sequence may arise as a result of recombination between inexact repeats. Because the end repeat blocks within the A-and B-repeat regions of the M6 sequence diverge slightly from the consensus sequence of the three internal blocks, recombination between one of these terminal blocks and any other central block can generate a new sequence. These changes may then be amplified by recombination events within these repeated sequences. Sequences involved in antigenic determinants may be duplicated or in some cases deleted by such recombination events (95) . Thus, intragenic recombination events would be expected to accelerate the rate at which alterations accumulate in the M-protein gene. Such recombination events were found to have occurred in the A-and B-repeat regions of deletion mutants isolated in the laboratory from strain D471 (Fig. 9) . In mutant M6.5, derived from M6.1, a deletion of the equivalent of two repeat blocks occurred from a recombination event beginning from the center of the divergent Al repeat block to the center of the consensus A3 block. This resulted in a sequence change from an Asp-Lys (D-K) to an Asp-Asn (D-N) within this mutant (107) (Fig. 11) (77, 94) . Identical residues are boxed. Lowercase a and d above the sequence designate the positions of these residues in the seven-residue periodicity (a, b, c, d, e, f, and g) based on the alignment in Fig. 7 . A 29-residue gap was introduced in the MS sequence to maximize the number of identities since the MS sequence in this strain is shorter than that represented in Fig. 12. M19 (unpublished strain) (34) proteins. In addition, the C-terminal one-third of M5 (strain T5B/126/4), M19 (strain (SS400), M24 (strain (C98/135/2), M30 (strain 6GL130), and M55 (strain A92817311) is also available (96) . Like the differences observed among the various M6 strains (Fig. 9) , alignment of the M-protein sequences from M6, MS, and M24 serotypes reveals differences among the three in the number and size of the repeat blocks (Fig. 12) . In these three serotypes, in addition to M19, M30, and M55 (96), a highly conserved region (>98% identity) is found C terminal to the D repeat (located within the cell wall), and, depending on the serotypes being compared, sequence variation increases among these types as the N terminus is approached (Fig. 8) . Strong sequence homology is observed among these three types within the C-repeat region; however, this homology is greatly reduced in the B-repeat region and nearly lost in the A-repeat region. The extent of homology depends on the serotypes being compared, some types being more related than others. For instance, the C-repeat blocks between M6 and M5 and between M6 and M24 are about 80% identical; however, the B blocks in M6 are not very homologous to those in M24 (18% identity) but are significantly homologous to those in M5 (54% identity) (Fig. 12) . The homology of the B blocks between M5 and M24 is <10%. In the M24 sequence, all of the A repeats have been deleted, leaving an extended nonrepetitive region N terminal to the B repeat. A similar pattern is seen in the sequence of the pepsin fragment of the M49 sequence; however, in this sequence, remnants of an A-repeat region still exist (not shown) (116) .
The preceding discussion serves to illustrate the differences in the sequence and repeat blocks for the M protein from these specific serotype strains. M proteins from different strains of the same serotype are likely to differ in size from the prototype strain and will exhibit differences in sequence as well as immunodeterminants depending on the nature of the size variation. For instance, the major difference between the N-terminal half of M5 from strain B788 (112) and M5 from strain Manfredo (148) is a 14-residue insertion in the A-repeat region of strain B788 and a 25-residue insertion in the B-repeat region of strain Manfredo. Therefore, strain designations are critical when comparisons are to be made between different M proteins. Although very few M sequences are currently known, it is clear that certain serotypes are more closely related than others based on the degree of homology within the B-and C-repeat segments (28, 108, 109) . Perhaps, as more data are gathered on other M proteins, the evolution of the M serotypes will become more apparent.
Alignment of the Variable Region of Two Different M Proteins
The sequence of PepM5 protein from strain B788 (133), comprising the N-terminal half of the native M5 molecule (to the C-terminal end of the B-repeat region), was compared with the corresponding region of the M6.1 sequence (from strain D471) (77, 94) . Maximal homology is achieved if a gap of 29 residues is introduced in the M5 sequence. This is necessary since the M molecules from these two strains differ in size, M5 being smaller ( Fig. 13) Although the number of identities within the hypervariable region of these two molecules (residues 1 to 163 of M6 and 1 to 133 of M5) is far less than those in the region C terminal to these segments, half (22 of 47) of the identities are either asparagine or hydrophobic amino acids that occupy core residues at positions a and d of the heptad periodicity (Fig.  7) . It is clear that hydrophobic residues in these positions are required for the maintenance of the coiled-coil structure of the M protein (136, 164) . Therefore, in spite of considerable sequence dissimilarity between these two M molecules within the hypervariable region, identities are preserved in critical structural positions. Thus, the maintenance of the coiled-coil rod region appears to be a biologically significant characteristic of the M molecule (76, 77, 141 
HOMOLOGY OF M PROTEIN WITH OTHER MOLECULES OF GRAM-POSITIVE BACTERIA
Group C and G Streptococci M protein or M-like proteins of group A streptococci have been reported in group B (142), C (142, 217), E (58), and G (142, 143) streptococci. These conclusions are based either on serological cross-reactions with typing sera developed to M protein from group A organisms or on the ability of these organisms to resist phagocytosis. DNA hybridization analysis was performed to define better the relationship of the M protein from group A streptococci with that of other streptococcal groups (183) . By using nearly the complete M6 protein gene as a probe, homologous DNA is found in group C and G streptococci but not other groups (183) . Group C streptococci are primarily animal pathogens but have been implicated in serious human infections (151) . Group G organisms are found as part of the normal flora of the skin, upper respiratory tract, and female genital tract. However, these organisms are responsible for an increasing number of human diseases (4, 6, 142) .
Monoclonal antibodies prepared to the M6 protein from group A streptococci cross-react with a protein found on group G clinical isolates (105) . More than half of the group G strains examined are resistant to phagocytosis in human blood. When surface protein is extracted from group G cells with the muralytic enzyme mutanolysin and reacted in Western blots with M-protein-specific monoclonal antibodies, the protein pattern resembles that seen with M protein from group A organisms. A highly purified, pepsin-derived protein fragment from a group G strain was capable of inducing antibodies in rabbits which opsonized group G cells in a phagocytosis assay (105) . In a separate study, group G streptococcal clinical isolates were found to survive in human blood and shown to exhibit surface fibers by electron microscopy. Rabbit antisera to either whole group G streptococci or partially purified pepsin extracts were also opsonic for homologous isolates (31 (2) . Analysis of the DNA sequence reveals that the C-terminal end of protein G is highly homologous to the M-protein C-terminal membrane anchor and a small portion of the wall domain, with 56% identical residues (61, 159) (Fig. 14) . Although there is some sequence homology between the remaining portion of protein G and M protein, the most striking feature lies in the presence of sequence repeat blocks. Like M protein, the repeat blocks divide protein G into distinct domains. A repeat domain located within the C-terminal half of the molecule, proximal to the cell wall, is responsible for the IgG-binding activity of protein G (89), while the albumin-binding activity is located in the Nterminal repeat domain (3) . Although protein G is rich in a-helix-forming residues, a detailed analysis concerning its conformation as a coiled-coil structure has not as yet been performed.
S. equi, a Lancefield group C organism, is the causative agent of "strangles," a disease of horses resembling human pharyngitis. Reports of an M-like molecule with the ability to render these streptococci resistant to phagocytosis are well documented (189, 196, 217 (Fig. 14) (61, 159) . The homology among these three proteins is even more striking when conservation of charge or hydrophobicity is considered. The conservation of sequence and chemical properties of amino acids within the C-terminal region suggests that there likely exists a common mechanism by which protein A, protein G, and M protein are anchored to the gram-positive cell wall. Although protein A does not exhibit (x-helical coiled-coil potential (159), the repetitive nature of the sequence (198) is reminiscent of the repeats found in both M protein (94) and protein G (61) . While serological differences between protein A molecules on various staphylococcal strains has not yet been reported, the presence of size variation among clinical isolates has recently been described (38) . (99) . In subsequent studies, homologies with tropomyosin were also observed with other M sequences, namely. MS and M6 (136) . Many of the observed identities correspond to the core hydrophobic amino acids in positions a and d in the seven-residue repeat pattern necessary to maintain the coiled-coil (refer to Fig. 7 and section on structure) (77. 136, 164) . However, in certain regions, identities are also found in externally positioned amino acids. It was suggested that the correlation between sequences in M protein and tropomyosin provides direct evidence, at a molecular level, of a structural similarity between a streptococcal and a mammalian protein, and this similarity may be relevant in the pathogenesis of streptococcal diseases (99, 150) .
Other Coiled-Coil Molecules An analysis of the PepM5 sequence revealed that the periodicity and sequence of this M protein more closely resemble the coiled-coil rod region of myosin than tropomyosin (138, 141 (166, 190 (190) . While it would be tempting to speculate on the possible role of these homologies in the pathogenesis of certain streptococcus-related diseases, it would be best to await the results of future experiments.
IMMUNOLOGICAL CROSS-REACTIVITY BETWEEN M PROTEIN AND MAMMALIAN PROTEINS
Heart-Reactive Antibodies
Cross-reactions have been observed between streptococcal components and mammalian tissue. Kaplan and Meyeserian (113) described a component of M5 and M19 streptococcal cell walls which induces antibodies reactive with muscle tissue and correlates with M protein. Zabriskie and Freimer (219) observed that purified streptococcal membranes evoked cross-reactive antibodies which reacted with human cardiac muscle sarcolemma. While subsequent attempts were made to identify these cross-reactive antigens from the streptococcus (200) . they have not been characterized sufficiently to determine their identity.
Immunodeterminants Shared with Myosin and Other
Human Proteins Dale and Beachey (54) discovered that rabbits immunized with PepM5 protein produced antibodies which cross-react with myosin but not tropomyosin or actin. By enzyme-linked immunosorbent assay, the cross-reactive epitope is also found in the M6 and M19 proteins and is exposed on the surface of the streptococcus. Furthermore, these investigators found that the M5 molecule contains at least three epitopes which stimulate antibodies to human sarcolemmal membranes and are partially shared with M6 and M19 proteins (53) . One of the myosin cross-reactive epitopes was localized to amino acids 84 to 116 of the M5 sequence (56) .
More recently. Sargent et al. (179) . using antibodies to eight synthetic peptides representing the entire PepM5 protein, determined that peptide stimulates antibodies in rabbits which react with isolated cardiac sarcolemmal membranes but not with purified myosin. The reactivity is localized to a 40-kDa protein in the sarcolemmal membrane. The results indicate that the epitope located in the sequence is shared with M6 but not M24 or M19. This sequence is located close to the center of the native M5 molecule (within the B-repeat region), N terminal to the pepsin-susceptible site. This segment is highly conserved between the M5 and M6 proteins (77) (Fig. 13) but not M24.
Synthetic peptides representing the N-terminal 20 amino acids of M5 (57) and M6 (15) proteins were found to evoke type-specific protective but not heart-reactive antibodies. These studies suggested that, by using sequences from the N-terminal end of the M molecule, heart-reactive epitopes might be avoided. However, subsequent experiments (34) revealed that PepM19 and synthetic peptides representing residues 1 to 24 of M19 evoked both opsonic antibodies and heart-reactive antibodies to a sarcolemmal protein, indicating that epitopes stimulating autoimmunity may also be localized within the type-specific N-terminal region.
Renal Tissue-Associated Epitopes Shared with M Protein Sera from patients with poststreptococcal glomerulonephritis are shown to have antibodies against basement membrane antigens (63 15 . Alignment of the sequence of M6 protein and human cardiac tropomyosin in a region exhibiting significant homology. Lowercase letters a through g directly above the sequence designate the positions of these amino acids within the seven-residue pattern (a-b-c-d-e-f-g) in both segments based on previous analysis (77, 191) . Lowercase letters b, c, g, e, and f identify these external locations in the heptad repeat. Double dots indicate identities and single dots are conservative substitutions. Below, a cross sectional view of a coiled-coil (looking down the helices from the N terminus) revealing the relative position of residues a to g in the structure (adapted from McLachlan and Stewart [145] ). Positions a and d are nonpolar and, thus, internalized in the formation of the coiled-coil. This reveals that the identities in positions b, c, g, e, e, f, c, e, b, c would be clustered nearly contiguously along the outer face of the coiled-coil. membrane type IV collagen and laminin. It is speculated that the cross-reactivity may be related to structural similarity between the streptococcal M protein and basement membrane antigens such as laminin. More recently, it has been shown that monoclonal antibodies prepared to renal cortex cross-react with M proteins from type 6 and 12 streptococci (87) . These studies were extended to type 1 M protein, in which antisera raised in rabbits to a synthetic peptide representing the N-terminal 1 to 26 amino acids and a similar peptide lacking residues 20 to 22 both were able to opsonize Ml streptococci and react with human renal glomeruli by immunofluorescene (119) . The cross-reactive epitope was localized to the tetrapeptide Ile-Arg-Leu-Arg located at residues 23 to 26 in the Ml peptide, while the region responsible for eliciting the opsonic antibodies was residues 1 to 20. The Ile-Arg-Leu-Arg sequence has not been found in other M-protein sequences such as MS, M6, and M24, which are not considered nephritogenic serotypes. However, it was also not part of the M49 sequence, a nephritis-associated serotype (116) . The authors state that this result indicates that the observed tetrapeptide may not be the only sequence defining a renal autoimmune epitope (119).
Monoclonal Antibodies Cross-Reactive with Coiled-Coil Proteins
Cunningham and Russell (49) prepared monoclonal antibodies to streptococcal membranes from M5 streptococci which cross-react with detergent-extracted human heart sarcolemmal antigens. The monoclonal antibodies react more strongly with heart antigens than with kidney or skeletal muscle antigens. Some of the monoclonal antibodies are directed to skeletal muscle myosin, and one is reactive with ventricular myosin. The myosin-reactive antibody could be absorbed with either myosin or whole streptococci (121) . Two monoclonal antibodies reactive with M5 protein and a streptococcal membrane protein were found to be polyspecific. One reacts with DNA, polyinosinic acid, polydeoxythymidylic acid, and cardiolipin, and its reactivity with the cytoskeleton could be blocked with antivimentin (50) ; the other reacts with the cytoskeleton and is inhibited by the a-helical proteins myosin, actin, and keratin. Further characterization of these monoclonal antibodies revealed that they are specific for epitopes in the heavy chain of myosin: one for light meromyosin and the other for both light and heavy meromyosin. Both of these myosin fragments contain a portion of the coiled-coil rod region. The authors speculate that the induction of antibody-producing clones against myosin by a streptococcal antigen may explain at least some of the cross-reactive responses seen during streptococcal sequelae. Recently, Fenderson et al. (62a) described the production of monoclonal antibodies which react with M5 and M6 proteins and human and rabbit tropomyosin. At least one of these cross-reactive monoclonal antibodies also exhibits strong reactivity with human heart tissue by immunofluorescence.
Conformational Determinants
Since many of the M-protein cross-reactive antibodies (48, 50, 56, 119, 121) also react with other coiled-coil proteins (i.e., myosin, tropomyosin, keratin, vimentin, etc.), it is likely that in several cases the immunological recognition is based on a common conformational determinant. Sequence alignments between M protein and tropomyosin (Fig. 15) , as well as between other cross-reactive coiled-coil molecules, do not reveal a common linear sequence (Fischetti, unpublished data (94, 180) . The M protein produced in E. coli (ColiM6) was shown to react with both monoclonal and polyclonal antibodies prepared to the streptococcus-derived M6 protein. The cloned molecule accumulates in the periplasmic space of E. coli, and no M protein is detected on the surface of E. co/i or in the growth supernatant (73) . A small amount of M protein is present in the cytoplasm, where its molecular size is larger than the periplasmic form. This is consistent with the idea that the larger molecule retains the hydrophobic leader sequence prior to export to the periplasm.
The M-protein genes from M5 (115), M12 (175) , and M24 (153) streptococcal serotypes have also been cloned and shown to produce immunologically active M proteins. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the cloned M6 molecule appears as a close triplet of bands.
a characteristic also seen with the cloned M5 protein (171) . The reason for the multiple banding pattern is not entirely understood, but seems to be associated with the C-terminal region, since pepsin cleavage of ColiM6 results in a Cterminal fragment which retains the triple banded structure (72) while the N-terminal half (or PepM) is homogeneous (21, 34, 72, 137) .
Relationship of M-Protein Genes
The relationship of the emmn-6 gene in M6 streptococci to emm genes in other streptococcal serotypes was determined by hybridization experiments, using the enmm-6.1 gene as a probe (183) . The results revealed that DNA from all of the 56 different serotypes tested contain homologous cmiui genes.
Among the group A streptococci tested in these studies were several which were functionally M-(i.e., those phagocytized in human blood). An e(mm gene could be identified in all but one M-strain. The reason for the M-phenotype in emm1117-containing strains is not known, but may reflect a defect at the level of translation or transcription of M protein.
Localization of the region in the emin gene responsible for hybridization with all tested serotypes was accomplished by hybridizing DNA from 10 different serotypes with smaller probes derived from the emm-6.1 gene. This investigation revealed that the 3' region of the emim-6. / gene is conserved among these serotypes while the 5' segment is variable (182) . A similar result was also reported when DNA probes corresponding to the 5' and 3' ends of the einmn-5 gene (their snp5 notation for the gene) were used in hybridization studies with DNA from heterologous M serotypes (114) . These findings corroborated earlier results of studies which used monoclonal antibodies with defined epitopes to identify the variable and conserved segments of the M molecule (109) .
Ribonucleic acid sequence analysis of emm gene transcripts primed with specific oligonucleotide probes from emnm-6.I was used to determine the degree of homology within the 3' end of the emmn-5, emm-19, emmn-24, emnm-30. and emmn-55 genes (96) . The results revealed that the Cterminal one-third of these genes are >95% identical to emnmn-6.1. This was later confirmed with the reported sequence from other strains of M5 (148) and M24 (153) proteins.
Conversion of M-to M+ Phenotype DNA hybridization studies demonstrated that M-strain T28/51/4 lacked an emm gene (183) , and electron microscopy revealed that this strain has no surface fibrils associated with the presence of M protein (193) . In addition, this strain is easily phagocytized in normal human blood (193) . With a specially constructed shuttle vector, experiments were designed to move the cloned emm-6.I gene into this emimdeficient streptococcus (181) . The resultant transconjugant was converted to M6', resistant to phagocytosis in human blood, and opsonized by anti-M6 antiserum. Immunofluorescence studies revealed that M6 protein was located on the cell surface of the transconjugant. When inoculated into rabbits, the transconjugant induced opsonic antibodies to M6 streptococci. In a similar set of experiments, the emnin-5 gene was transformed into S. sanguis, and M5 protein was demonstrated on the cell surface by immunofluorescence (171) . Although producing less M protein than authentic M5 streptococci, these organisms removed opsonic antibodies from anti-M5 serum, indicating that the antiphagocytic determinants are expressed on the surface of S. sanguis. Thus. the emm-6.1 and emnm-5 genes contain all information necessary to convert an M-streptococcus to a biologically and immunologically MX organism, further emphasizing the role played by M protein in the antiphagocytic capacity of streptococci.
Number of emm Gene Copies As stated earlier, one copy of the emin gene is detected in an M6 strain (183) and in the chromosome of nine different serotypes as determined by Southern hybridization with M6 gene probes (182) . This supports the hypothesis that recombination leading to size and antigenic variation is an intragenic event. However, in contrast, two bands were found to hybridize with a digest of the M5 chromosomal DNA. This result may be due to restriction site heterogeneity for this M5 strain or the presence of two einmn-5 gene copies in the M5 organisms. The latter possibility is supported by Kehoe et al. (115) . who identified two copies of an emmn-5 gene in a strain different from the one used in the studies by Scott et al. (182) . Since these were the only two reported studies of VOL. 2, 1989 on October 26, 2017 by guest http://cmr.asm.org/ Downloaded from CLIN. MICROBIOL. REV. emmn-5 genes, it is not certain whether the presence of two einin genes in M5 streptococci is the rule or whether these strains are unusual.
Regulation of the emm Gene Lancefield observed that streptococcal strains maintained in the laboratory for extended periods of time (several weeks to a few months) lose their ability to survive in human blood (129) . Quantitative measurements of the M-protein content suggest that these streptococci do not contain sufficient M protein for survival (24, 129) . Passage of these organisms through mice or human blood results in the surviving streptococci producing higher quantities of M protein (24), suggesting that a regulatory mechanism may be responsible for M-protein expression.
Cleary et al. (40) found that M12 strain CS44 produced Mmutants at high frequency which correlated with a variation in colony morphology. Spanier et al. (188) isolated two Mmutants from this population, which, by Southern blot analysis, were found to contain a small deletion in a region upstream from the M12 structural gene promoter. In a recent analysis of these strains and derivatives thereof, it was determined that the deletion was about 500 base pairs upstream of the emm-12 gene (186) . Although this characteristic could not be confirmed in other M serotypes, these results suggest that a positive regulator may be located upstream from the M-protein structural gene.
A positive regulator for the production of M protein was also suggested by the experiments of Scott et al. (181) , in which a plasmid containing the emm-6.1 gene and its promoter was transferred to a strain lacking an emm gene (T28/ 51/4). Even though the plasmid was present in a high copy number, the production of M6 protein was about 30-to 50-fold less than in the parental M6 strain from which the emm-6.1 gene was derived. They suggested that the emrndeleted strain may also be deleted for a positive regulator necessary for wild-type expression. By using Tn9l6 mutagenesis in D471, the strain from which the emm-6.1 gene was derived, a mutant was found which produced 50-fold less M protein than the parental strain. By Southern blot analysis, it was shown that the Tn insertion was about 2 kilobases upstream from the emm-6.1 structural gene. Northern (ribonucleic acid) blot analysis revealed that the mutant did not produce any detectable emm-6.1-specific messenger ribonucleic acid. Thus, the authors named the gene responsible for this effect mry, for M-protein ribonucleic acid yield.
In support of the hypothesis that the emrn-deleted strain T28/51/4 was unable to sustain full emm expression, Southern blot hybridization revealed that this strain was in fact deleted for the may gene (35) . Thus, a positive regulator appears to be necessary for high M-protein expression. Whether environmental factors play a role in this expression or whether, like certain positive regulators in other pathogens (149, 206) , mnry controls other virulence determinants in the streptococcus requires further study.
HUMAN IMMUNE RESPONSE TO THE M MOLECULE
In earlier experiments designed to examine the human immune response to the M protein as a result of a streptococcal infection, it was clear that, once infected with a specific streptococcal serotype, an individual remained protected from subsequent infection by strains of that serotype but was susceptible to other streptococcal types (see review by Lancefield [1291). This limited protection was based on the development of type-specific opsonic antibodies to the M molecule which were found to persist years after a streptococcal infection (128) . However, after such an infection, measurable amounts of opsonic antibodies are usually delayed when compared with the response to other streptococcal antigens (124, 125, 176) . In more recent studies with competitive inhibition assays with purified M protein, it was discovered that type-specific opsonic sera contained antibodies directed to a majority of the immunodeterminants on the M molecule while nonopsonic sera did not (64) . Thus, it was suggested that, for some reason, opsonic antibodies are produced late during an immune response to the M protein.
Immunodominant Region of the M Molecule To define further the development of an immune response to the total M6 protein, synthetic peptides representing 82% of the native molecule were examined for reactivity with rabbit and human sera by kinetic enzyme-linked immunosorbent assay (78) . The results reveal that rabbits immunized with the native M protein or whole streptococci respond by reacting first and predominantly to one of the three sequence repeat regions of the molecule, namely, the B repeat. Antibodies to this region have recently been shown to be nonopsonic (106) . Antibodies to peptides representing the variable N-terminal and adjacent A-repeat regions appear only when opsonic antibodies are detected in the serum. Antibodies to peptides located within the conserved Cterminal half of the molecule are limited even after several immunizations. By the same assay, an examination of human sera revealed that those sera opsonic for M6 streptococci contain antibodies reactive predominantly to the Nterminal and A-repeat regions. Nonopsonic human sera to M6 streptococci show low reactivity to most peptides. By Western blot analysis of the N-and C-terminal halves of the M6 molecule, all human sera tested contain antibodies to the conserved C-terminal half, while only sera opsonic for M6 streptococci react with the N-terminal variable half. The authors suggest that antibodies to the C-terminal half are primarily directed to conformational determinants and thus may not react with small synthetic peptides (78) .
The immunodominant nature of the B-repeat region could explain the observed delay in the appearance of opsonic antibodies in human sera after exposure to M-protein-positive streptococci (124, 125, 176) . It is possible that an exaggerated response to the nonopsonogenic B repeat may in some way affect the response to the adjacent regions. It also explains the observed presence of high levels of binding antibodies to the M molecule in the absence of opsonic activity. That M6 antibodies to the N-terminal and A-repeat segments were elevated in the M6 opsonic human sera is in keeping with the observation of Lancefield (128) 
N-Terminal Charge Domain
The mechanism by which the M molecule exerts its antiphagocytic effect has been elusive since its discovery nearly 60 years ago. Despite sequence variation within the N-terminal hypervariable region of the M molecules, a common feature found in the sequence of M5 (139) , M6 (77) , M24 (153) , and M49 (116) is a concentration of acidic amino acids within this segment. These residues occur predominantly in external positions within the coiled-coil structure (77) . Some of these amino acids likely enter into salt bridge formation between the two M-protein chains and function to stabilize the coiled-coil (165), while others become hydrated and contribute to the net negative charge in this region. While the exact function of this conserved charge domain is not known, it has been suggested that it may contribute to the antiphagocytic property of the molecule (66, 136, 139) by hampering contact between the streptococcus and the phagocyte by electrostatic repulsion. In support of this idea, it was found that, when opsonic IgG was fractionated into acidic and basic components, the opsonic activity was localized in the IgG population that was most basic in charge while nonopsonic binding antibodies were located in the other charged IgG populations (66) . This suggests that the basic antibodies bind to the more acidic regions of the M molecule (i.e., the N-terminal region) and thereby neutralize the negative charge.
Effect on Phagocytic Cells
In attempts to determine whether the M protein on the whole streptococcus impairs the phagocytic capacity of neutrophils, M streptococci were rendered nonviable with mitomycin and used at 150-fold excess over phagocytes in a bactericidal assay containing a small number of viable phagocytosis-susceptible streptococci (140) . The results revealed that the phagocytes could effectively seek out and destroy the relatively few susceptible streptococci in the presence of the excess M' cells. Thus, the nonviable M+ streptococci did not interfere with the phagocytic activity of the neutrophils. When these experiments were repeated with live streptomycin-susceptible M + and streptomycin-resistant M-streptococci, to select for M-survivors on streptomycin plates, similar results were obtained (Fischetti, unpublished data) . This helped to rule out the possible effects of mitomycin or nonviable organisms in the previous experiments. Hence, in the presence of M ' streptococci, the phagocytes are not preoccupied by attempting to phagocytize the M+ cells: they simply ignore them.
Complement
The alternative complement pathway is considered to be an important part of the nonspecific defense system against infection (155) . The Factor H The deposition of C3b on the surface of particles is amplified by particle-bound C3 convertase, also termed C3b,Bb, which is a labile enzyme complex that activates C3 (154) . Specific inhibitors such as decay-accelerating factor and factor H prevent C3 activation by rendering C3b susceptible to inactivation by factor I. Factor H is a 150-kDa ,3-globulin present in serum (500 jg/ml) and functions to control fluid-phase as well as surface-bound C3b (205) .
While the studies of Jacks-Weis et al. (103) demonstrate that M' streptococci bind less C3b than M-cells, the deposition on M' cells was found to be uneven compared with the more uniform distribution of C3b on M-organisms. Horstmann et al. (98) , using purified complement components instead of serum, did not find any difference in either the deposition or the inactivation of C3b or the dissociation of the C3b,Bb complex on the surface of M+ and Mstreptococci when complement regulatory proteins were omitted. In fact, both strains exhibited a spontaneous decay of the C3b,Bb complex similar to zymosan-bound C3b,Bb which served as a control. However, when purified factor H was added to streptococcus-bound C3b, the cofactor activity of factor H for the cleavage of C3b by factor I was six to eight times higher when C3b was bound to M+ streptococci instead of M-organisms. M+ five different serotypes, as well as purified M protein, were found to bind factor H with dissociation constants as high as 6 x 10' M, emphasizing the functional significance of this binding reaction.
It was proposed that the antiphagocytic action of the M protein may be explained by this finding. When a streptococcus contacts serum, the M protein specifically binds factor H to its surface. Any C3b fixed in the vicinity of this complex is controlled by factor H, which inhibits or reverses the formation of C3b,Bb complexes and serves as a cofactor in the conversion of C3b to iC3b by factor I. Thus, the low numbers of C3b molecules deposited on the M streptococcus will prevent C3b-dependent phagocytosis. The regulation of complement deposition by binding factor H to a bacterial surface appears to be a novel route by which a pathogen is able to evade alternative pathway activation and phagocytic clearance.
Fibrinogen
Kantor (110) found that a component in partially purified acid extracts of group A streptococci precipitated fibrinogen.
In a number of studies, the active component was subsequently found to be M protein (101, 110, 152, 207, 209) . Similar binding characteristics for fibrinogen were found for other streptococcal groups (C and G), suggesting that Mprotein analogs are also present on these organisms (122) . In attempts to examine the role of this interaction with regard to the antiphagocytic action of the M protein, Whitnack and Beachey (207) (218) may explain why fibrinogen-coated streptococci (208) adhere to but are not ingested by these phagocytic cells. Thus, since the assay used in many of these studies measures phagocyte association, the role of fibrinogen in streptococcal clearance is not completely defined. There is also strong evidence that LTA secreted from the streptococcus mediates direct contact with the epithelial cell surface. M protein or another surface molecule might facilitate this process by anchoring and orienting the LTA adhesin so that the lipid moiety is able to make contact with the epithelial cell (20) . Studies also suggest that M-positive streptococci can attach to epithelial cells by a mechanism independent of LTA. When M+ and M-streptococci are tested for their binding capacity to human pharyngeal, buccal, and tongue epithelial cells, the M ' bacteria attach in signficantly higher numbers to the pharyngeal than to the buccal or tongue cells (197) . The M-organisms bind in equivalent low numbers to all three oral cell types. While M I streptococci could be inhibited from binding to pharyngeal cells by using the complete M6 protein molecule as well as LTA, 1,000-fold more LTA than M protein is required to attain equivalent inhibition.
M protein binds specifically to F actin, forming regular parallel bundles of actin filaments in solution (36) . In addition to isolated M protein, whole M' streptococci also bind specifically to F-actin filaments. While M protein does not compete with tropomyosin for binding to actin, it does compete with myosin subfragment 1 as a result of this interaction. While the biological implication of this binding is unclear at this time, it is becoming more apparent that actin is present on the surface of a number of cell types such as fibroblasts (184) , lymphocytes (160) , and human B cells (5) . Therefore, the interaction of streptococcal M protein with surface actin on a host cell may be a possible event. Thus, while there may be multiple mechanisms by which streptococci can attach to epithelial cells, it seems apparent that M protein provides the organism with an adherence advantage; consequently, it is considered to be an attachment factor.
M-PROTEIN VACCINES
Type-Specific Protection Since the observation by Lancefield that antibodies to the M protein have the capacity to opsonize streptococci in preparation for phagocytic clearance (126) , the M protein has been a prime candidate for a vaccine to prevent group A streptococcal infections. Fox has reviewed the trials and tribulations of the early attempts in M-protein vaccine development (81 Encouraged by these studies, Beachey and co-workers embarked on a systematic approach to develop methods by which a type-specific epitope-based vaccine could be developed to protect against streptococcal disease. It was quickly learned that peptides representing the first 20 or so Nterminal amino acids of M24 protein evoked type-specific opsonic antibodies to M24 streptococci (17) . Experiments with synthetic peptides of the N terminus of MI, MS, M6, and M19 proteins resulted in the same conclusions (12, 15, 23, 34, 107, 179) . When a hybrid peptide was synthesized from the sequence of the M24 and MS proteins and injected into animals in complete Freund adjuvant, opsonic antibodies were produced to both MS and M24 streptococci (12) . Opsonic antibodies to three M proteins were obtained when the N-terminal sequences of three M-protein sequences (MS-M6-M24) were synthesized in tandem and injected into rabbits (16) .
Attenuated Salmonella typhimarium has also been used effectively for delivering the M-protein antigen in a mouse model (174 21) and within the A-repeat block (106) , which begins at amino acid 27 and continues to residue 96 (77, 94) . As mentioned previously, high-frequency intragenic recombinational events within the A-repeat block region can lead to a significant loss in the opsonizing ability of monospecific antibody (107) . However, to date little information is available on mechanisms for generating antigenic variation at the extreme amino-terminal nonrepeat region. A second major concern for type-specific epitopebased vaccines centers on the antigenic diversity of the more than 80 serological types of M protein. Certain serotypes are more likely than others to be associated with severe cases of pharyngitis or outbreaks of rheumatic fever; thus, the number of distinct type-specific determinants incorporated into a vaccine can be limited to some extent (28) Non-Type-Specific Protection The incidence of group A streptococcal respiratory infection rises sharply at age 4, peaks at age 6, and rapidly declines above age 10, reaching adult levels by 18 years (32). At its peak incidence, 50% of children between the ages of 5 and 7 suffer from streptococcal infection each year. The decreased incidence of streptococcal pharyngitis in adults might be explained by an age-related host factor. Alternatively, protective antibodies directed to antigens common to all group A streptococcal serotypes might arise as a consequence of multiple infections experienced during childhood, resulting in an elevated response to conserved protective epitopes of the M molecule. In exploring the second hypothesis, it was found that sera of most adults examined have a strong antibody response to the conserved regions of M6 protein (27a, 78) . While antibodies directed to conserved epitopes fail to neutralize the antiphagocytic property of M protein (106), they might afford protection by an alternative mechanism. Kurl et al. (123) found that whole-cell vaccines consisting of type 12, 18, 30, 49, 50, or 55 streptococci were equally as efficient at protecting mice immunized intranasally from lethal infection after challenge with M50 streptococci. The authors suggest that local immunity against M50 streptococci could be achieved by a nonspecific mechanism; however, the molecular components of the streptococcus involved in eliciting this protection were not defined.
It should be emphasized at this juncture that humans are the only reservoir for group A streptococci, and except for M type 50, which is naturally virulent for mice (97) , all other serotypes need to be adapted to the animal being considered as a possible model for streptococcal disease. For instance, group A streptococci isolated fresh from human infection are not virulent for mice, and nearly 107 CFU need to be administered intraperitoneally to cause death within 1 to 2 days (129). However, after such a passage in the mouse (usually several passages are required), a strain is isolated which will cause death with a dose of <10 CFU. For some group A strains, a mouse-virulent organism may not be isolated. Although the amount of M protein increases after mouse passage, its role in mouse virulence is not completely defined (93 Secretory IgA is a major first-line defense against bacterial infections of the mucosal epithelium (118) , and it has been $ 9 9 6~~~demonstrated that M-protein-specific secretary IgA can provide significant protection against streptococcal infection in a mouse model (26, 27a, 67) . Passive (27 (Fig. 7) were covalently linked to the mucosal adjuvant cholera toxin B 11 protect mice from lethal streptococcal chalsubunit and administered intranasally to the mice. About 1 homologous serotype (59) . month later, animals were challenged intranasally with live at region of MG protein is highly conserved streptococci and pharyngeal colonization was monitored for coccii of many distinct serological types (27a, 15 days. It was found that mice immunized with the cholera 109). Monoclonal antibodies directed to detertoxin B subunit-peptide complex showed a significant reducized to the C-repeat region of M6 protein bind tion in colonization compared with mice receiving cholera of whole streptococci which represent more toxin B subunit alone (Fig. 16) . Thus, despite the fact that e serotypes examined (108, 109) . Despite these conserved-region peptides are unable to evoke an opsonic er et al. (147) (27) . The achievement of non-type-specific protection in animal models (27, 123, 216) 
